Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment
Crossref DOI link: https://doi.org/10.1038/onc.2015.13
Published Online: 2015-03-30
Published Print: 2015-11-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tian, H
Liu, J
Chen, J
Gatza, M L
Blobe, G C
Text and Data Mining valid from 2015-03-30
Version of Record valid from 2015-03-30
Article History
Received: 8 September 2014
Revised: 17 December 2014
Accepted: 5 January 2015
First Online: 30 March 2015
Competing interests
: The authors declare no conflict of interest.